METRA BIOSYSTEMS INC
SC 13G/A, 1998-08-05
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: FIRST TRUST SPECIAL SIT TR SER 34 HEALTHCARE TR 2000 SER 1, 497J, 1998-08-05
Next: LIGHTPATH TECHNOLOGIES INC, 4, 1998-08-05




                          UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549
                     -----------------------

                           SCHEDULE 13G
                          (Rule 13d-102)

           INFORMATION TO BE INCLUDED IN STATEMENTS FILED

                         METRO BIOSYSTEMS                       
                  ------------------------------
                         (Name of Issuer)

                             Common
          ----------------------------------------------
                  (Title of Class of Securities)

                            591591102
                ---------------------------------
                          (CUSIP Number)




CUSIP No. 591591102

1    NAME OF REPORTING PERSONS

     Zesiger Capital Group LLC
     I.R.S. Identification No. 13-3813880

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*      (a)__
                                                            (b) 
     N/A

3    SEC USE ONLY

4    CITIZENSHIP OR PLACE OF ORGANIZATION

     New York, New York

                         5    SOLE VOTING POWER
                              100,000
NUMBER OF
SHARES                   6    SHARED VOTING POWER
BENEFICIALLY                  N/A
OWNED BY
EACH                     7    SOLE DISPOSITIVE POWER
REPORTING                     221,533
PERSON WITH
                         8    SHARED DISPOSITIVE POWER
                              N/A  

9    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     221,533

10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
     SHARES*                                                  

     N/A

11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 

     1.8%

12   TYPE OF REPORTING PERSON*

     Investment Advisor (IA)







CUSIP No. 591591102
                    
ITEM 1(a).  Name of Issuer

            Metra Biosystems

ITEM 2(a).  Address of Issuer's Principal Executive Offices:

            265 North Whisman Roaad
            Mountain View, CA  94043-3911

Item 2(a).  Name of Person Filing:

            Zesiger Capital Group LLC

Item 2(b).  Address of Principal Business Office or if None, Residence:

            320 Park Avenue, 30th Floor, New York, New York  10022

Item 2(c).  Citizenship:

            New York

Item 2(d).  Title of Class of Securities:

            Common Stock

Item 2(e).  CUSIP Number:

            591591102

Item 3.     If this statement is filed pursuant to Rule 13d-1(b), or
            13d-2(b), check whether the person filing is a(n):

            (e)  Investment Advisor registered under section 203 of
                 the Investment Advisors Act of 1940

Item 4.     Ownership.

            If the person of the class owned, as of December 31 of the
            year covered by this statement, or as of the last day of any
            month described in Rule 13d-1(b)(2), if applicable, exceeds
            five percent, provide the following information as of that
            date and identify those shares which there is a right to
            acquire.

            (a)  Amount Beneficially Owned
                 

            (b)  Percent of Class
                 

            (c)  Number of shares as to which such person has:

                 (i)    sole power to vote to direct the vote
                        

                 (ii)   shared power to vote or to direct the vote

                        

                 (iii)  sole power to dispose or to direct the disposition
                        

                 (iv)   shared power to dispose or to direct the disposition
                        of                   
                     
                        
Item 5.     Ownership of Five Percent or Less of a Class.

            This statement is being filed to report the fact that as of the
            date hereof the reporting person has ceased to be the beneficial
            owner of more than five percent of the class of securities.

Item 6.     Ownership of More than Five Percent on Behalf of Another Person
      
            N/A

Item 7.     Identification and Classification of the Subsidiary Which
            Acquired the Security Being Reported on By the Parent Holding
            Company

            N/A

Item 8.     Identification and Classification of Members of the Group

            N/A

Item 9.     Notice of Dissolution of the Group

            N/A

Item 10.    Certification

            By signing below I certify that, to the best of my knowledge
            and belief, the securities referred to above were acquired in
            the ordinary course of business and were not acquired for the
            purpose of and do not have the effect of changing or
            influencing the control of the issuer of such securities and
            were not acquired in connection with or as a participant in any
            transaction having such purpose or effect.

                                    SIGNATURE

            After reasonable inquiry and to the best of my knowledge and
            belief, I certify that the information set forth in this
            statement is true, complete, and correct.

            
                                          August 4, 1998
                                          Date:

                                          Barrie R. Zesiger
                                          Principal - Administration



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission